Company Updates
New Patent Application for Leaf Resources (ASX:LER) Leads to Commercial Interest
Australian Securities Exchange Announcement, 13 April 2015 Highlights: Leaf Resources has lodged a new patent application for HybritechTM – a platform for the flexible production of pulp and/or cellulosic sugars The HybritechTM platform addresses a strategic focus of paper and pulp producers A US focused business development campaign in the paper and pulp industry is currently […]
Connexion Media March 2015 Quarterly Review
17 April 2015, Melbourne, Australia: After its ASX listing in August 2014 Connexion Media Limited (ASX:CXZ) has generated strong news flow and sealed major deals with leading global car manufacturers for our two core products,miRoamer and Flex. miRoamer Our MirrorLink-enabled miRoamer Android application for radio and music services has seen solid progress since its launch at the […]
Proteomics International Laboratories (ASX:PIQ) Lists on the ASX
ASX/Media Release, 16 April 2015 ASX code: PIQ Emerging life science company Proteomics International Laboratories Ltd (proposed ASX: PIQ) is pleased to announce it will list on the ASX at 12:00pm AWST today after successfully closing its IPO. The strong level of investor interest in the IPO is a reflection of the major growth potential of […]
NewActon East Property Fund to Proceed with FY16 Distribution Forecast at 8.25%
Latest Highlights: • Fund well received by investors. Expected to close by mid this year • 8.25% FY16 Forecast Distribution • Interest rates 100% hedged until 30 September 2019 • Property 100% leased • Commonwealth Government provides 80% of property income Placer Property is pleased to announce that the NewActon East Property Fund will proceed […]
Prescient Therapeutics Latest Update
Prescient Therapeutics (formerly Virax Holdings) is a clinical stage oncology company developing novel targeted approaches to treat cancers of high unmet need, such as advanced breast, ovarian, multiple myeloma and acute leukemia. The company raised A$3M in June 2014 and has in the last 6-months acquired a deep pipeline of products through strategic company acquisitions. […]
Prescient Therapeutics Takes Center Stage at the Roth Conference 2015
Prescient Therapeutics (formerly Virax Holdings) is a clinical stage oncology company developing novel targeted approaches to treat cancers of high unmet need, such as advanced breast, ovarian, multiple myeloma and acute leukemia. The company raised A$3M in June 2014 and has in the last 6-months acquired a deep pipeline of products through strategic company acquisitions. […]
Castle Point Investment Commentary – April
The latest Castle Point Investment Commentary is now available. Please click here to view or alternatively paste this link into your browser – www.castlepointfunds.com/quarterly_commentaries For our first Investment Commentary of 2015 there are four articles: Portfolio Review and Outlook First Day IPO Performance Good Corporate Governance Step Ladder on Everest We start with a review of the Ranger […]
mm2 Asia Acquires 51% of the Issued Share Capital of Vividthree Productions
The Board of Directors (the “Board”) of mm2 Asia Ltd. (the “Company”, and together with its subsidiaries, the “Group”) refers to its announcement on 3 March 2015. The Board wishes to announce that its wholly-owned subsidiary, mm2 Entertainment Pte. Ltd (“Buyer”), has on 8 April 2015 entered into a sale and purchase agreement (the “SPA”) […]
mm2 Asia To Acquire Majority Stake in Leading 3D Animation Services Company for S$3.06m
Singapore, 9 April 2015 Following a term sheet inked in March 2015, newly-listed local movie producer and distributor, mm2 Asia Ltd.(“mm2 Asia” and together with its subsidiaries, the “Group”) today announced that it has entered into a sales and purchase agreement (“SPA”), through its wholly-owned subsidiary, mm2 Entertainment Pte Ltd (the “Buyer”), to acquire a 51% […]
Backed By Leading Investment Groups and Family Offices
